Agilex Biolabs expands with a new Flow Cytometry Laboratory at QIMR Berghofer, boosting speed and precision in clinical research.
Contracted by the South Australian Government, Agilex Biolabs is deploying world-class science to sa...
Introduction – A New Chapter in Drug Development The use of biomarkers in medicine is not new....
By Dr Hayley Kain, Pharmacokinetic Scientist at Agilex Biolabs Rapid Data. Smarter Decisions. No...
By Dr. Kurt Sales, CSO Summary The following article focuses on the use of flow cytometry in c...
By William Grenfell, Head of IT In today's digital age, information security is paramount. At Agi...
By Kim Salvatore, Head of Client and Operational Services The bioanalytical and drug development...
By Dr. Kurt Sales, CSO Peripheral Blood Mononuclear Cells (PBMC) are critical for the pharmacodyn...
We took some time to sit down and talk with Jason so you could get to know him a bit better... My...
We took some time to sit down and talk with Cameron so you could get to know him a bit better......
We took some time to sit down and talk with Dr Sales so you could get to know him a bit better......
Agilex is pleased to introduce Mallory Jolly as our new Senior Business Development Director to the...
Agilex Demystifies the Rapidly Evolving Landscape of Drug Development Post-Covid, the field of bi...
애질렉스 바이오랩스가 힐리어스 네트워크의 일원으로서 글로벌 확장과 기업 발전을 지속하는 가운데, 스티븐 맥킨타이어가 최고경영자(CEO)로 선임되었습니다.
How do Australia's streamlined regulatory process and global tax incentive apply to your toxicology...
애질렉스 바이오랩스가 힐리어스 네트워크의 일원으로서 글로벌 확장과 기업 발전을 지속하는 가운데, 스티븐 맥킨타이어가 최고경영자(CEO)로 선임되었습니다.
by Holly Stefl, Chief Commercial Officer It is with much enthusiasm that Agilex Biolabs introduce...
by Holly Stefl, Chief Commercial Officer Agilex Biolabs is proud to introduce the West Coast of t...
호주 임상시험을 지원하는 선도적인 바이오 분석 연구소인 Agilex Biolabs는 호주 애들레이드에 위치한 CMAX 임상 연구 시설 5층에 고도로 전문화된 기술자로 구성된 첫 번째 위성 처리 부서를 설립했습니다.
애질렉스 바이오랩스가 힐리어스 네트워크의 일원으로서 글로벌 확장과 기업 발전을 지속하는 가운데, 스티븐 맥킨타이어가 최고경영자(CEO)로 선임되었습니다.
애질렉스 바이오랩스는 지난 11월 21일, 바이오스펙트럼 아시아 엑설런스 어워드에서 '임상 연구 기반 개발 분야 최고 기업' 부문 에디터스 초이스 어워드의 올해의 수상자로 선정되었습니다.
호주 임상시험을 지원하는 선도적인 바이오 분석 연구소인 Agilex Biolabs는 호주 애들레이드에 위치한 CMAX 임상 연구 시설 5층에 고도로 전문화된 기술자로 구성된 첫 번째 위성 처리 부서를 설립했습니다.
애질렉스 바이오랩스는 새로운 생체 내 테스트 시설을 오픈하여 생명공학, 제약 및 동물 건강 산업에 더 나은 서비스를 제공할 수 있는 역량을 확장했습니다.
Dr. Kurt Sales Appointed as Chief Scientific Officer at Agilex Biolabs Kurt Sales as Chief Scient...
Learn how to improve Bioanalytical clinical outcomes by performing MetID characterisation. Leading...
Large Molecule Facility Doubles Size of Australia’s Top Bioanalytical Laboratory Agilex Biolabs...
This year, we at Agilex Biolabs celebrate our 25th year supporting Biotechs’ d...
Agilex Biolabs Pty Ltd has been purchased by one of Australia’s leading healthcare companies, Healius Limited
Agilex Biolabs Congratulates VGI Health Technology Limited for successful filing of a new PCT Patent Application on Transmucosal Delivery of Tocotrienols
With the integration of leading toxicology company TetraQ into Agilex Biolabs’ service offering, A...
Meet the Scientists series - Meer Dr Jason Geue, R& D Manager at Agilex Biolabs.
Agilex Biolabs, Australia’s most experienced and technologically advanced bioanalytical laboratory and the only biolab in the region with a dedicated toxicology unit, has been selected as a finalist for the Most Successful Early Phase Research (Preclinical & Phase I) category in the Citeline Awards 2021.
Agilex Biolabs, the Australian specialist bioanalytical and toxicology laboratory facilities for clinical trials is partnering with Endpoints News to share the latest on “Non-clinical and clinical pathways for rapid vaccine development in Australia”, in a webinar hosted by Endpoints News Editor Arsalan Arif.
Agilex Biolabs, Australia’s largest and most technologically advanced regulated bioanalytical laboratory for clinical trials is showcasing its new $1.5m vaccine and immunobiology laboratory at BIO Asia Taiwan 2021. The facility, the most sophisticated in APAC, is designed for biotechs and pharma from around the world for advanced clinical research including RNA vaccines, siRNA/miRNA clinical targets and gene therapy studies.
Over the past 2 years, Agilex Biolabs has invested more than $3.5m in technology and systems at the APAC headquarters in Adelaide.
Over the past 2 years, Agilex Biolabs has invested more than $3.5m in technology and systems at the APAC headquarters in Adelaide.
Agilex Biolabs, Australia’s largest and most technologically advanced regulated bioanalytical laboratory for clinical trials today announced that the Premier of South Australia the Hon Steven Marshall MP has launched its new $1.5m vaccine and immuno-biology laboratory. The facility, the most sophisticated in APAC, will attract biotechs and pharma from around the world for advanced clinical research.
Over the past 2 years, Agilex Biolabs has invested more than $3.5m in technology and systems at the APAC headquarters in Adelaide.
Over the past 2 years, Agilex Biolabs has invested more than $3.5m in technology and systems at the APAC headquarters in Adelaide.
Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials announced for BIO Korea 2021 that their upgraded and expanded biolabs at the Australian headquarters is now complete.
The labs have been expanded by 30% to cater for increased demand for bioanalysis and biomarkers in clinical studies from clinical stage biotechs.
The labs have been expanded by 30% to cater for increased demand for bioanalysis and biomarkers in clinical studies from clinical stage biotechs.
Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials is partnering with Endpoints News to share the latest on deconvoluting inflammation and immunology for clinical trials, in a webinar hosted by Endpoints News Editor Arsalan Arif.
Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, said biotechs with first-in-human studies can leverage significant quality, speed and cost advantages working with their company TetraQ toxicology for pre-clinical research in Australia.
TetraQ is a NATA-accredited, GLP-recognised rodent toxicology facility.
TetraQ is a NATA-accredited, GLP-recognised rodent toxicology facility.
Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, today announced the purchase of leading biolab TetraQ, based out of the University of Queensland.
Agilex Biolabs CEO Jason Valentine said the Board and senior management at Agilex Biolabs were extremely pleased with the purchase of such a high-calibre bioanalytics company.
“TetraQ complements the Agilex Biolabs work in Australia and APAC with its expert staff and years of experience in regulated bioanalytical services,” he said.
Agilex Biolabs CEO Jason Valentine said the Board and senior management at Agilex Biolabs were extremely pleased with the purchase of such a high-calibre bioanalytics company.
“TetraQ complements the Agilex Biolabs work in Australia and APAC with its expert staff and years of experience in regulated bioanalytical services,” he said.
Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, today announced it will showcase its world-class immunoassay and immunobiology services for regulated bioanalysis at Bio-Europe 2021.
Are you a highly experienced Study Director with proven experience in developing and validating flow cytometry assays (immunophenotyping and receptor occupancy assays) and/or cell-based neutralising or mode of action assays in a regulatory environment?
Agilex Biolabs, Australia’s most advanced FDA-inspected specialist bioanalytical laboratory for clinical trials, today announced the roll-out of the GALEXI™ client portal for real-time study management.
Agilex Biolabs, Australia’s most advanced FDA-inspected specialist bioanalytical laboratory for clinical trials, today announced the roll-out of the GALEXI™ client portal for real-time study management.
Agilex Biolabs is the leading bioanalytical laboratory in Asia-Pacific with the most advanced platforms for sensitive technologies. They include Sciex API 6500+ LC-MS/MS, Sciex API 4000 LC-MS/MS systems; Gyrolab™ Xplore, Luminex MAGPIX xPONENT ™, MSD Quickplex 120 and BD FACSymphony™ A3 20 colour flow cytometry analysers, so we have the capability to deliver any sized project.
Agilex Biolabs, the leading APAC biolabs for biotech clinical trials, announced today the launch of a Client Portal named GALEXI™.
The Agilex Biolabs technology team, with its Microsoft partner, accelerated the launch of GALEXI™ to deliver secure and enhanced communications during continued COVID challenges globally.
The Agilex Biolabs technology team, with its Microsoft partner, accelerated the launch of GALEXI™ to deliver secure and enhanced communications during continued COVID challenges globally.
Title: Development and Validation of a PK Method for Tocilizumab in Both Singlicate and Duplicate on the Gyrolab Platform
Award-winning Agilex Biolabs, the Asia-Pacific region’s leading bioanalytical laboratory for clinical trials, based in Australia, has developed the world’s most accurate cannabinoid assay.
Agilex Biolabs, Australia’s largest specialist bioanalytical laboratory for clinical trials, and Endpoints News launched a new webinar “How Easy is it to Move Your Trials to Australia” at BIO Asia-Taiwan 2020.
https://youtu.be/WNdPGkdr9FA...
Award-winning Australian bioanalytical laboratory Agilex Biolabs announced today it has appointed US-based Dr Caroline Popper, MBBS, MPH as Board Chair as part of its APAC clinical trials bioanalytics growth plans.
Award-winning Australian bioanalytical laboratory Agilex Biolabs announced today it has appointed PhD and NHMRC Fellow Patrick Hughes as R&D Manager Immunobiology.
Award-winning Agilex Biolabs, the Asia-Pacific region’s leading bioanalytical laboratory based in Australia, announced a raft of new pharmacodynamics services for biotech and pharma clients conducting preclinical and clinical trials in Asia, US, EU and Australia.
Australia-based Agilex Biolabs announced a broad range of new pharmacodynamics services for biopharma clients running preclinical and clinical trials in the U.S., Asia, European Union and Australia.
Award-winning Agilex Biolabs, the Asia-Pacific region’s leading bioanalytical laboratory based in Australia, announced a raft of new pharmacodynamics services for biotech and pharma clients conducting preclinical and clinical trials in Asia, US, EU and Australia.
One of the most important drug development start-up decisions is finding a centrally located bioanalytical laboratory that can support clinical research across all the study locations, and through pre-clinical then potentially for all Phases.
Quality control and consistency of sample management and analysis from early Phase onwards can make a real difference to quality of data and final outcomes.
Quality control and consistency of sample management and analysis from early Phase onwards can make a real difference to quality of data and final outcomes.
Australia-based Agilex Biolabs, the Asia-Pacific region’s leading bioanalytical laboratory for global clients conducting preclinical and clinical trials, announced at AusBiotech 2019 today it has been selected as a Top 10 Bioanalytical Services Provider by PharmaTech Outlook Magazine (Booth #523).
Boston, MA – Agilex Biolabs, the Asia Pacific’s leading bioanalytical laboratory, announced...
https://youtu.be/UrlJI-Y--k0...
Agilex Biolabs, Australia’s leading bioanalytical laboratory for global clients
conducting preclinical and clinical trials announced at DIA 2019 this week it will analyse more than 60,000 samples in 2019 (June 23-27 San Diego, CA) Booth 2006.
conducting preclinical and clinical trials announced at DIA 2019 this week it will analyse more than 60,000 samples in 2019 (June 23-27 San Diego, CA) Booth 2006.
